2022 Annual Convention - Day 2

Lunch Symposium 1 (Boehringer Ingelheim)

Prof. Janaka Karralliedde: Looking Closer at the Brilliance of SGLT2 inhibitors in addressing the CRM system in T2D management


Lunch Symposium 2 (Servier)

Anthony Russel Villanueva, MD and Nemencio Nicodemus, MD : Single Pill Combination Therapy in Hypertension: Far Beyond Treatment Simplification


Lunch Symposium 3 (Astra Zeneca)

Bien Matawawan, MD and Brian Michael Cabral, MD : From Science to Patients: Bringing Protection to LIFE


Lunch Symposium 4 (LRI Therapharma)

Nestor Eric Laplano, MD : Effective Glucose-Lowering Therapies in Patients with Diabetic Kidney Disease: The Vildagliptin Experience


Plenary 4

Nemencio Nicodemus Jr, MD : Philippine Thyroid Cancer Guideline 2022


Plenary 5

Bart Clarke, MD : Glucocorticoid- and Transplant-Induced Osteoporosis: Updates on Prevention and Treatment


Snack Symposium 1 (Woerwag Pharma)

Nemencio Nicodemus Jr, MD : Diabetic Neuropathy Review and Updates


Snack Symposium 2 (Otsuka)

Maria Cristina San Jose, MD : Dual Anti-platelet Therapy for Stroke Prevention: Why, When and How?


Snack Symposium 3 (Corbridge)

Maria Honolina Gomez, MD : Revisiting Endothelial Glycocalyx and GAGs


Snack Symposium 4 (Fresenius Kabi)

Froilan de Leon, MD : 2020 KDOQI Guidelines and Implications on Ketoanalogues Therapy


Concurrent Symposium 1: In-Hospital Management of Endocrine Diseases

Ruby Go, MD: Optimizing the Treatment of Steroid-Induced Hyperglycemia

Joselynna Anel-Quimpo, MD: Diagnosis and Comprehensive Management of Thyroid Storm

Vivien Lim, MD: A Practical Approach in Managing Hypercalcemic Crisis


Concurrent Symposium 2: Trends in Endocrinology and Metabolism

Cecilia Jimeno, MD: Dyslipidemia in Type 1 Diabetes: A Masked Danger

Roberto Mirasol, MD: An Endocrine Perspective in the Diagnosis and Management of NAFLD and NASH

Brian Michael Cabral, MD: Neglected Complications of Chronic Kidney Disease and Mineral Bone Disorders


Plenary 6: Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms

Zanariah Hussein, MD: Role of the Endocrinologist in the Management of Neuroendocrine Tumors

Patricia Bautista-Penalosa, MD: Theranostic Promise for Neuroendocrine Tumors

Gerardo Thomas Cornelio, MD: Chemotherapy in Neuroendocrine Tumors


Dinner Symposium 1 (Sanofi)

Cynthia Manabat, MD : Broadening Perspectives: Evidences of Fixed-Ratio Combination Therapy across the Globe


Dinner Symposium 2 (Abbott Laboratories)

Roberto Mirasol, MD and Rosa Allyn Sy, MD : When Two Pandemic Collide: New Consensus Guidelines


Dinner Symposium 3 (Novo Nordisk)

Nemencio Nicodemus Jr, MD and Carolyn Narvacan-Montano, MD : Real World Evidence on New Generation Insulins


Dinner Symposium 4 (GX International)

Prof. Soo Lim : DPP-4 inhibitors as an Attractive Option for Type 2 Diabetes: Rationale and Clinical Implications